Miltenyi Biotec Is A Global Biotechnology Company Founded In 1989 By Physicist Stefan Miltenyiheadquartered In Bergisch Gladbachgermanythe Company Has Grown To Employ Over 4 500 Staff And Achieved A 880 Million In Sales In 2022With Expectations To Surpass A 1 Billion In 2023Miltenyi Biotec Operates Gmp Facilities In Germany And The U S Along With Additional Locations Across Europeasiaand North America The Company Specializes In Immunologystem Cell Biologyneuroscienceand Cancer Researchfocusing On Developing Tools And Therapies That Connect Basic Research With Clinical Applicationskey Technologies Include Magnetic Cell Sortingmacsa For Automated Cell Separationclinimacsacell Factories For Manufacturing Gene Modified Cellsand Gene Sequencing Tools For Biomedical Researchmiltenyi Biomedicinea Subsidiary Established In 2019Is Dedicated To Developing Blood Cancer Treatmentsthe Company Is Recognized For Its Strong Position In Cell Separation Technologies And Has Experienced Consistent Growth Driven By The Increasing Demand For Personalized Therapies
